Biobanking and Digital Pathology in the Context of the UN Sustainable Development Goals

The integration of biobanking and digital pathology represents a transformative advancement in medical research and healthcare delivery, aligning closely with several United Nations Sustainable Development Goals (UN SDGs). This session explores the critical role of biobanking and digital pathology in enhancing global health outcomes, reducing inequalities, and fostering innovation in medical sciences. By systematically collecting, storing, and analyzing biological samples and associated data, biobanking facilitates groundbreaking research in understanding disease mechanisms, leading to more effective treatments and preventive strategies. Digital pathology, through advanced imaging and artificial intelligence, revolutionizes diagnostic accuracy and efficiency, promoting accessible and high-quality healthcare.

Key discussions will highlight how these technologies support SDG 3 (Good Health and Well-Being) by advancing precision medicine, improving disease surveillance, and enabling robust public health responses. The session will also address their impact on SDG 9 (Industry, Innovation, and Infrastructure), showcasing how biobanking and digital pathology drive technological innovation and support the development of resilient healthcare infrastructures. Furthermore, we will explore contributions to SDG 10 (Reduced Inequalities), emphasizing equitable access to cutting-edge medical advancements and personalized care across diverse populations.

By bridging scientific research with clinical practice, biobanking and digital pathology embody a holistic approach to achieving the UN SDGs, fostering sustainable and inclusive development in global health. This session aims to inspire collaborative efforts among researchers, healthcare professionals, policymakers, and stakeholders, driving forward a shared vision of a healthier, more equitable world.